Efficacy and safety of Canagliflozin (CANA), an inhibitor of Sodium Glucose Co-Transporter 2 (SGLT2), added on to insulin therapy with or without oral agents in type 2 diabetes (T2D)

2013 ◽  
Vol 8 (S 01) ◽  
Author(s):  
D Matthews ◽  
G Fulcher ◽  
V Perkovic ◽  
D de Zeeuw ◽  
KW Mahaffey ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Therapy ◽  
Efficacy And Safety ◽  
Oral Agents

Efficacy and Safety of Continuing Sitagliptin when Initiating Insulin Therapy in Subjects with Type 2 Diabetes Mellitus

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 112-LB ◽  
Author(s):  
RONAN ROUSSEL ◽  
SANTIAGO DURAN-GARCIA ◽  
YILONG ZHANG ◽  
SUNERI SHAH ◽  
CAROLYN DARMIENTO ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Insulin Therapy ◽  
Efficacy And Safety

Efficacy and safety of linagliptin to improve glucose control in older people with type 2 diabetes on stable insulin therapy: A randomized trial

2019 ◽  
Vol 21 (11) ◽  
pp. 2465-2473 ◽  
Author(s):  
Gilbert Ledesma ◽  
Guillermo E. Umpierrez ◽  
John E. Morley ◽  
Diane Lewis‐D'Agostino ◽  
Annett Keller ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Older People ◽  
Insulin Therapy ◽  
Randomized Trial ◽  
Glucose Control ◽  
Efficacy And Safety
Sign in / Sign up

Export Citation Format

Share Document